Global  

Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Video Credit: ANI - Duration: 01:21s - Published
Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine

Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India.

He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance.

He said, "3 vaccines are at clinical trial stage in India.

Cadila and Bharat Biotech have completed phase-I trials.

Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."


You Might Like


💡 One News Page Knowledge: Other News Mentions

Balram Bhargava Indian science administrator

‘No vaccine for respiratory diseases has 100% efficacy’

No vaccine for respiratory diseases has a 100% efficacy and ones with a 50-100% efficacy may be approved for use against the Covid-19 pandemic, Indian Council..
IndiaTimes
Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.

Credit: HT Digital Content    Duration: 01:19Published
Second national sero-survey to be completed in September first week: ICMR [Video]

Second national sero-survey to be completed in September first week: ICMR

Indian Council of Medical Research, Director General Dr. Balram Bhargava during Health Ministry's briefing on COVID-19 situation in India informed about the sero survey publication. Bhargava said, "ICMR sero survey is publication in-progress. It should appear by this week in the Indian Journal of Medical Research. It has been peer reviewed. The second national sero-survey should be completed in the first week September". On situation of COVID-19 vaccines in India, Balram Bhargava said, "Three COVID-19 vaccines are ahead in the race in India. Serum Institute's vaccine is in phase 2(B) and phase 3 trials and Bharat Biotech and Zydus Cadila's vaccines have completed phase 1 trial."

Credit: ANI    Duration: 01:49Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Birmingham crash witnesses sought as injured man has Covid-19

A handful of people had close contact with a man hit by a car who has tested positive for Covid-19.
BBC News
Nicola Sturgeon: R number possibly as high as 1.6 in Scotland [Video]

Nicola Sturgeon: R number possibly as high as 1.6 in Scotland

Nicola Sturgeon said the R number in Scotland – the average number of otherpeople infected with the virus by each person with Covid-19 – could nowpossibly be as high as 1.6. Speaking at the start of First Minister’sQuestions at Holyrood, she said the latest figures showed why the ScottishGovernment had announced further “tough measures” aimed at curbingcoronavirus.

Credit: PA - Press Association STUDIO    Duration: 01:30Published
Why Iraqi COVID doctors fear for their safety [Video]

Why Iraqi COVID doctors fear for their safety

Iraqi doctor Tariq Al-Sheibani remembers little else beyond cowering on the ground as a dozen relatives of a patient, who had just died of COVID-19, beat him unconscious. Lauren Anthony.

Credit: Reuters Studio    Duration: 02:17Published

Indian Council of Medical Research Indian Council of Medical Research organization

Country crosses 56-lakh mark with 83,347 new infections [Video]

Country crosses 56-lakh mark with 83,347 new infections

India's COVID-19 tally crossed 56-lakh mark on September 23 with a spike of 83,347 new infections. Total COVID-19 cases in the country stand at 56,46,011. Currently, there are 9,68,377 active cases. With 1,085 deaths in last 24 hours, the death toll rises to 90,020. Indian Council of Medical Research reported that 6,62,79,462 samples were tested up to September 22. Further, the Health Ministry informed that India's COVID-19 testing capacity surges to over 12 lakh daily tests.

Credit: ANI    Duration: 01:18Published
COVID-19: India crosses 55-lakh mark with 75,083 new infections [Video]

COVID-19: India crosses 55-lakh mark with 75,083 new infections

India's COVID tally crossed 55-lakh mark on September 22 after the country reported a spike of 75,083 new COVID-19 cases. Total COVID case tally stands at 55, 62,664, including 9,75,861 active cases, 44,97,868 discharged. With 1,053 deaths in the last 24 hours, death toll due to COVID reached 88,935. Indian Council of Medical Research reported that 6,53,25,779 samples were tested up to September 21 for the virus. Of these, 9,33,185 samples were tested on September 21.

Credit: ANI    Duration: 01:15Published

Containment zones’ sero survey data sent to states: ICMR

ICMR said it has communicated to states the findings of a serosurvey in "dynamic containment zones" in 10 cities, which "do not fit into the..
IndiaTimes

Second round of COVID-19 serosurvey completed: ICMR

The Indian Council of Medical Research (ICMR) on Sunday (September 20, 2020) informed that second countrywide serosurvey for COVID-19 has been successfully..
DNA

Cadila Healthcare Cadila Healthcare Indian multinational pharmaceutical company

Covid update: India vaccine progress; another minister infected; IMF on economy [Video]

Covid update: India vaccine progress; another minister infected; IMF on economy

From another minister in the Narendra Modi cabinet testing positive for infection, to the progress report of India's indigenously-developed vaccine candidates - here are the top news updates on the Covid-19 pandemic. Union minister of petroleum and natural gas, and steel, Dharmendra Pradhan, tested positive days after Union Home minister Amit Shah confirmed his positive diagnosis. Meanwhile, other members of the Union cabinet, like Ravi Shankar Prasad and Babul Supriyo, are quarantining themselves as a precaution. On the medical front, India's two vaccine candidates have completed phase 1 of human clinical trials. The vaccines have been developed by Bharat Biotech, ICMR and Zydus Cadila. The Jammu and Kashmir administration has decided to allow all places of worship to reopen from August 16. Earlier, the authorities had decided to cancel the annual Amarnath Yatra due to the Covid pandemic. In economic news, the International Monetary Fund has said that Covid might exacerbate the narrowing of global current account imbalances which was happening due to trade slowdown in 2019. Watch the full video for the other updates on the spread of the Sars-CoV-2 coronavirus.

Credit: HT Digital Content    Duration: 02:41Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech's Covid vaccine [Video]

PGI Rohtak to start phase-2 human clinical trial of Bharat Biotech's Covid vaccine

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine. “We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We've 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed,” said Dr OP Kalra, vice-chancellor, PGI Rohtak. Kalra also informed that in the phase-2 trail, they have recruited volunteers who have controlled diabetes and high blood pressure. Watch the full video for more details.

Credit: HT Digital Content    Duration: 01:48Published

Tweets about this


Related videos from verified sources

Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials [Video]

Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials

The drugmaker made the announcement on Wednesday, joining the ranks of Pfizer and Moderna who have been in Phase 3 trials since July.

Credit: Cover Video STUDIO     Duration: 01:22Published
EJ Espresso: UK will infect volunteers with Covid to test vaccine [Video]

EJ Espresso: UK will infect volunteers with Covid to test vaccine

J&J kicks off final trial of single-shot Covid vaccine. UK will infect volunteers with Covid to test vaccine. Rape case against Anurag Kashyap on actor's complaint. And have you seen ex-Bihar DGP's..

Credit: HT Digital Content     Duration: 07:15Published
Fall Arrives As US COVID-19 Cases, Deaths On The Rise Again [Video]

Fall Arrives As US COVID-19 Cases, Deaths On The Rise Again

With over 200,000 Americans having been killed by COVID-19 already, the United States is now transitioning into a new season with alarming trends. Experts caution the country could be facing a..

Credit: Wochit Entertainment     Duration: 00:40Published